
Person deep dive
Greg Winter
Sir Greg Winter is a Cambridge biochemist who shared the 2018 Nobel Prize in Chemistry for his work on antibody drugs. He co-founded Cambridge Antibody Technology, bought by AstraZeneca for £702M in 2006, Domantis, bought by GlaxoSmithKline for £230M in 2006, and Bicycle Therapeutics, listed on Nasdaq in 2019.
- Founded
- Immutrin, Bicycle Therapeutics, Domantis +1 more
- Education
- University of Cambridge
Track record
Companies Greg Winter founded or backed, with what became of them.
Cambridge Antibody TechnologyCo-founded in 1989 with David ChiswellBought by AstraZeneca for £702M in 2006- DDomantisFounded in 2000Bought by GlaxoSmithKline for £230M in 2006
Bicycle TherapeuticsCo-founded in 2009 on bicyclic peptide work from his lab with Christian HeinisListed on Nasdaq in 2019
Career
- 1973Graduated in natural sciences from Trinity College, Cambridge.
- 1981Became a group leader at the MRC Laboratory of Molecular Biology in Cambridge.
- 1986Developed the technique to humanise antibodies, the basis of many antibody drugs.
- 1989Co-founded Cambridge Antibody Technology, which discovered the antibody later sold by Abbott as Humira.
- 2000Founded Domantis to develop drugs from small antibody fragments.
- 2004Was knighted.
- 2006AstraZeneca bought Cambridge Antibody Technology for £702M, and GlaxoSmithKline bought Domantis for £230M.
- 2009Co-founded Bicycle Therapeutics.
- 2012Became Master of Trinity College, Cambridge, a post he held until 2019.
- 2018Shared the Nobel Prize in Chemistry with Frances Arnold and George Smith.
- 2019Bicycle Therapeutics listed on Nasdaq, raising about $60.7M.
Sources: Wikipedia: Greg Winter · Wikipedia: Cambridge Antibody Technology · Global Venturing: Bicycle Therapeutics squares $60.7m IPO circle · EPFL: Bicycle Therapeutics floats on Nasdaq · Dealroom: Greg Winter.
Companies founded

Immutrin
$514.8M valuation (2026)
→

Bicycle Therapeutics
$234.8M valuation (2026)Unicorn
→

Domantis

Cambridge Antibody Technology
Work history
Past roles by Dealroom records.

MRC Laboratory of Molecular Biology
Education

University of Cambridge